SEC Info - Polymedix, Inc - ‘10-K’ for 12/31/11

SEC Info℠

Home

Help

Please Sign In

Polymedix, Inc – ‘10-K’ for 12/31/11 – ‘EX-31.2’

On: Tuesday, 3/13/12, at 4:30pm ET · For: 12/31/11 · Accession #: 1341843-12-4 · File #: 0-51895

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/13/12  Polymedix, Inc                    10-K       12/31/11   34:4.5M

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report -- form10k                            HTML    887K 
 2: EX-3.2      Amended and Restated Bylaws                         HTML    122K 
 3: EX-10.22    Jorgensen Employment Agreement                      HTML     37K 
 4: EX-21       List of Subsidiaries                                HTML     10K 
 5: EX-23.1     Consent of Deloitte & Touche                        HTML     13K 
 6: EX-31.1     CEO 302 Certification                               HTML     18K 
 7: EX-31.2     CFO 302 Certification                               HTML     18K 
 8: EX-32       906 Certification                                   HTML     17K 
24: R1          Document And Entity Information                     HTML     39K 
18: R2          Consolidated Balance Sheets                         HTML    115K 
22: R3          Consolidated Balance Sheets (Parenthetical)         HTML     36K 
25: R4          Consolidated Statements of Operations               HTML     69K 
32: R5          Consolidated Statement of Changes in Stockholders'  HTML    195K 
                Equity                                                           
20: R6          Consolidated Statements of Cash Flows               HTML    124K 
21: R7          Organization and Business Activities                HTML     25K 
17: R8          Summary of Significant Accounting Policies          HTML     36K 
15: R9          Investments                                         HTML     20K 
33: R10         Fair Value Measurements                             HTML     39K 
27: R11         Accrued Expenses                                    HTML     24K 
26: R12         Provision for Income Taxes                          HTML     69K 
29: R13         Stockholders' Equity                                HTML    100K 
30: R14         Debt                                                HTML     33K 
28: R15         Derivative Financial Instruments                    HTML     25K 
31: R16         Commitments and Contingencies                       HTML     26K 
23: R17         Quarterly Financial Information (Unaudited)         HTML     51K 
34: XML         IDEA XML File -- Filing Summary                      XML     42K 
16: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS    377K 
 9: EX-101.INS  XBRL Instance -- pymx-20111231                       XML   1.04M 
11: EX-101.CAL  XBRL Calculations -- pymx-20111231_cal               XML     96K 
14: EX-101.DEF  XBRL Definitions -- pymx-20111231_def                XML     96K 
12: EX-101.LAB  XBRL Labels -- pymx-20111231_lab                     XML    605K 
13: EX-101.PRE  XBRL Presentations -- pymx-20111231_pre              XML    289K 
10: EX-101.SCH  XBRL Schema -- pymx-20111231                         XSD     61K 
19: ZIP         XBRL Zipped Folder -- 0001341843-12-000004-xbrl      Zip     70K

‘EX-31.2’ — CFO 302 Certification

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

C: C: C:

Exhibit 31.2

Certification

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Edward Smith, hereby certify that:

1. I have reviewed this report on Form 10-K of PolyMedix, Inc.;

2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and we have:

a) Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

d) Disclosed in this report any change in registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

March 13, 2012	By:	/s/ *Edward F. Smith*
Date		Edward F. Smith
		Vice President, Finance & Chief Financial Officer
		(Principal Financial and Accounting Officer)

Dates Referenced Herein

This ‘10-K’ Filing	Date	Other Filings

Filed on:	3/13/12	None on these Dates
For Period end:	12/31/11
		List all Filings

↑Top

Filing Submission 0001341843-12-000004 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)